Halberd

Halberd Net Debt

The Net Debt of Halberd (HALB) as of Oct 10, 2026 is 143,085.00 USD. In the previous year, Net Debt was 140,465.00 USD — a change of 1.87% (higher).

Net Debt

143,085.00USD

YoY

1.87%

Last updated:

Net Debt of Halberd is 2023 143,085.00 USD. Net Debt of Halberd was 2022 140,465.00 USD. It decreases by 1.87% higher compared to the previous year.

The Halberd Net Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt
Date
Net Debt
Jan 1, 2016
683,582.00 USD
Jan 1, 2021
109,679.00 USD
Jan 1, 2022
140,465.00 USD
Jan 1, 2023
143,085.00 USD
The Halberd Net Debt history
YEARNet DebtYoY
143,085.00USD+1.87%
140,465.00USD+28.07%
109,679.00USD-83.96%
683,582.00USD—
Access this data via the Eulerpool API
Get Free API Key

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

Net Debt of Halberd is 143,085.00 USD in 2023.

Net Debt of Halberd changed from 140,465.00 USD to 143,085.00 USD, representing a 1.87% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Halberd since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Halberd historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Halberd

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Halberd